MedPath

Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy

Not Applicable
Completed
Conditions
Marijuana Use
Pregnancy
Interventions
Behavioral: eSBIRT
Behavioral: Tailored texting
Registration Number
NCT02191605
Lead Sponsor
Wayne State University
Brief Summary

Marijuana is by far the mostly commonly used illicit drug during pregnancy, and prenatal exposure to marijuana can have lasting negative effects. However, current answers to this problem are failing to reach most women who use marijuana while pregnant. This project will develop and begin testing two technology-based, highly practical interventions that could reduce the number of children who are prenatally exposed to marijuana.

Detailed Description

There are at present no evidence-based interventions for marijuana use during pregnancy, despite its being by far the most commonly used illicit drug during pregnancy (particularly among African-American women), and despite growing evidence that it may have a range of long-term cognitive and neurobehavioral consequences. This R34 clinical trial planning grant therefore proposes the development and preliminary validation of two high- reach and mutually compatible technology-based interventions for marijuana use during pregnancy. The first, a theory-based, synchronous, and highly interactive computer-delivered brief intervention, will be based on an emerging knowledge base regarding key elements of efficacious technology-delivered interventions. The second intervention, a series of tailored text messages, will build on the rich literature regarding key tailoring elements. These interventions will be developed and refined with input from pregnant women who report active use of marijuana, as well as from health care providers. They will subsequently be tested-alone and in combination-in a pilot randomized trial involving 80 women actively using marijuana during pregnancy. This Stage I pilot work would set the stage for a confirmatory Stage II trial. It would also produce the first high-reach brief interventions for marijuana use during pregnancy. If effective, these approaches could have a substantial population impact on marijuana use among pregnant women, with potential for lifelong improved outcomes for both mother and child.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • 18 to 40 years of age
  • 20 weeks or less gestation
  • intention to carry pregnancy to term
  • self-reported marijuana use in month before pregnancy
  • own a cell phone and willingness to receive text messages
  • gives consent to access medical records for collection of birth outcome data
Exclusion Criteria
  • frank cognitive impairment or psychosis
  • not able to communicate in English
  • not planning to deliver at a Detroit Medical Center (DMC) hospital
  • previous or current participant in a study conducted by Dr. Ondersma
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Perinatal Research Branch participant.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
electronic SBIRT (eSBIRT)eSBIRTParticipants in this condition will receive empathic exploration of their thoughts regarding marijuana use, provision of information on possible consequences of marijuana use during pregnancy and potential benefits of changing use (with permission), normed feedback, use of Motivational Interviewing techniques to elicit their own reasons for change, video testimonials modeling successful change, and information on change methods with optional goal setting.
eSBIRT & textingeSBIRTParticipants in this arm will receive both the computerized intervention and tailored text messaging intervention as described in the eSBIRT and Tailored texting arms.
Tailored textingTailored textingParticipants in this condition will chose the frequency and time of text messages that will continue until childbirth or the participant opts out. The text messages will be a mix of marijuana targeted content (without directly referring to marijuana in a way that implies use by the participant) and general content related to healthy pregnancy; using appropriate humor and tips for community resources. Tailoring will focus on gestational age, self-efficacy, and social support.
eSBIRT & textingTailored textingParticipants in this arm will receive both the computerized intervention and tailored text messaging intervention as described in the eSBIRT and Tailored texting arms.
Primary Outcome Measures
NameTimeMethod
Number of Participants Abstinent From Marijuana for the 7 Days Prior to Deliveryself-reported use during 7 days prior to delivery of their baby

Marijuana use will be measured at the time of delivery of their infant by self-report (TimeLine Follow Back interview - TLFB) and urine analysis. This will represent the number of participants who abstinent (reported no marijuana use and had a negative toxicology urine screen) from marijuana for the 7 days prior to delivery.

Number of Participants Abstinent From Marijuana for the 90 Days Prior to Deliveryself-reported use during 90 days prior to delivery of their baby

Marijuana use will be measured at the time of delivery of their infant by self-report (TimeLine Follow Back interview - TLFB) and hair toxicology analysis. This will represent the number of participants who were abstinent (reported no marijuana use and had a negative hair toxicology results) from marijuana for the 90 days prior to delivery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wayne State University

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath